Anti-CRISPRs deconstruct bacterial defense

Nils Birkholz,Peter C Fineran

DOI: https://doi.org/10.1016/j.molcel.2024.08.008

2024-09-05

Abstract:Deploying anti-CRISPR proteins is a potent strategy used by phages to inhibit bacterial CRISPR-Cas defense. In a new Nature paper, Trost et al.1 discover and characterize an exciting anti-CRISPR mechanism with possible implications beyond this microscopic arms race.

What problem does this paper attempt to address?

Anti-CRISPR: discovery, mechanism and function

April Pawluk,Alan R. Davidson,Karen L. Maxwell

DOI: https://doi.org/10.1038/nrmicro.2017.120

IF: 88.1

2017-10-24

Nature Reviews Microbiology

Abstract:CRISPR–Cas adaptive immune systems are widespread in prokaryotes. In this Progress article, Maxwell and colleagues highlight how phages and other mobile genetic elements inactivate CRISPR–Cas systems using anti-CRISPR proteins and outline evolutionary and biotechnological implications of anti-CRISPR protein activity.

microbiology
A broad anti-anti-CRISPR strategy

Yi Zhang,Yue Feng

DOI: https://doi.org/10.1038/s41589-024-01743-w

IF: 14.8

2024-10-16

Nature Chemical Biology

Abstract:Prokaryotic CRISPR–Cas systems are counteracted by phage-encoded anti-CRISPR elements, and how they protect themselves remains enigmatic. A study shows that CRISPR-repressed toxins defend CRISPR–Cas against anti-CRISPR proteins or RNAs by inducing abortive infection.

biochemistry & molecular biology
Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering

Qiong Liu,Hongxia Zhang,Xiaotian Huang

DOI: https://doi.org/10.1111/febs.15139

Abstract:Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas adaptive immune defense systems, which are widely distributed in bacteria and Archaea, can provide sequence-specific protection against foreign DNA or RNA in some cases. However, the evolution of defense systems in bacterial hosts did not lead to the elimination of phages, and some phages carry anti-CRISPR genes that encode products that bind to the components mediating the defense mechanism and thus antagonize CRISPR-Cas immune systems of bacteria. Given the extensive application of CRISPR-Cas9 technologies in gene editing, in this review, we focus on the anti-CRISPR proteins (Acrs) that inhibit CRISPR-Cas systems for gene editing. We describe the discovery of Acrs in immune systems involving type I, II, and V CRISPR-Cas immunity, discuss the potential function of Acrs in inactivating type II and V CRISPR-Cas systems for gene editing and gene modulation, and provide an outlook on the development of important biotechnology tools for genetic engineering using Acrs.
If you can't beat them, join them: Anti-CRISPR proteins derived from CRISPR-associated genes

Charlie Y. Mo

DOI: https://doi.org/10.1016/j.chom.2024.10.009

IF: 31.316

2024-11-14

Cell Host & Microbe

Abstract:Bacteriophages have evolved numerous mechanisms to evade targeting by CRISPR-Cas defense systems. However, the evolutionary origin of these so-called "anti-CRISPRs" remains poorly understood. In a recent issue of Nature, Katz et al. provide evidence that some anti-CRISPRs were derived from genes of the CRISPR-Cas systems themselves.

microbiology,virology,parasitology
Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems

Fei Zhang,Guoxu Song,Yong Tian

DOI: https://doi.org/10.1002/ame2.12069

2019-05-29

Animal Models and Experimental Medicine

Abstract:CRISPR (clustered regularly interspaced short palindromic repeats)-Cas (CRISPR associated protein) systems serve as the adaptive immune system by which prokaryotes defend themselves against phages. It has also been developed into a series of powerful gene-editing tools. As the natural inhibitors of CRISPR-Cas systems, anti-CRISPRs (Acrs) can be used as the "off-switch" for CRISPR-Cas systems to limit the off-target effects caused by Cas9. Since the discovery of CRISPR-Cas systems, much research has focused on the identification, mechanisms and applications of Acrs. In light of the rapid development and scientific significance of this field, this review summarizes the history and research status of Acrs, and considers future applications.
The novel anti-CRISPR AcrIIA22 relieves DNA torsion in target plasmids and impairs SpyCas9 activity

Kevin J Forsberg,Danica T Schmidtke,Rachel Werther,Ruben V Uribe,Deanna Hausman,Morten O A Sommer,Barry L Stoddard,Brett K Kaiser,Harmit S Malik

DOI: https://doi.org/10.1371/journal.pbio.3001428

2021-10-13

Abstract:To overcome CRISPR-Cas defense systems, many phages and mobile genetic elements (MGEs) encode CRISPR-Cas inhibitors called anti-CRISPRs (Acrs). Nearly all characterized Acrs directly bind Cas proteins to inactivate CRISPR immunity. Here, using functional metagenomic selection, we describe AcrIIA22, an unconventional Acr found in hypervariable genomic regions of clostridial bacteria and their prophages from human gut microbiomes. AcrIIA22 does not bind strongly to SpyCas9 but nonetheless potently inhibits its activity against plasmids. To gain insight into its mechanism, we obtained an X-ray crystal structure of AcrIIA22, which revealed homology to PC4-like nucleic acid-binding proteins. Based on mutational analyses and functional assays, we deduced that acrIIA22 encodes a DNA nickase that relieves torsional stress in supercoiled plasmids. This may render them less susceptible to SpyCas9, which uses free energy from negative supercoils to form stable R-loops. Modifying DNA topology may provide an additional route to CRISPR-Cas resistance in phages and MGEs.
Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies

Nicole D. Marino,Rafael Pinilla-Redondo,Bálint Csörgő,Joseph Bondy-Denomy

DOI: https://doi.org/10.1038/s41592-020-0771-6

IF: 48

2020-03-16

Nature Methods

Abstract:Clustered, regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) genes, a diverse family of prokaryotic adaptive immune systems, have emerged as a biotechnological tool and therapeutic. The discovery of protein inhibitors of CRISPR-Cas systems, called anti-CRISPR (Acr) proteins, enables the development of more controllable and precise CRISPR-Cas tools. Here we discuss applications of Acr proteins for post-translational control of CRISPR-Cas systems in prokaryotic and mammalian cells, organisms and ecosystems.

biochemical research methods
Using CRISPR-Cas systems as antimicrobials

David Bikard,Rodolphe Barrangou

DOI: https://doi.org/10.1016/j.mib.2017.08.005

IF: 7.584

2017-06-01

Current Opinion in Microbiology

Abstract:Although CRISPR-Cas systems naturally evolved to provide adaptive immunity in bacteria and archaea, Cas nucleases can be co-opted to target chromosomal sequences rather than invasive genetic elements. Although genome editing is the primary outcome of self-targeting using CRISPR-based technologies in eukaryotes, self-targeting by CRISPR is typically lethal in bacteria. Here, we discuss how DNA damage introduced by Cas nucleases in bacteria can efficiently and specifically lead to plasmid curing or drive cell death. Specifically, we discuss how various CRISPR-Cas systems can be engineered and delivered using phages or phagemids as vectors. These principles establish CRISPR-Cas systems as potent and programmable antimicrobials, and open new avenues for the development of CRISPR-based tools for selective removal of bacterial pathogens and precise microbiome composition alteration.

microbiology
Anti-CRISPR with Non-Protein Substances.

Min Cao,Bingzhi Li,Xing Zhang

DOI: https://doi.org/10.1016/j.tibtech.2023.07.002

2024-01-01

Trends in Biotechnology

Abstract:Therapeutics based on clustered regularly interspaced short palindromic repeats (CRISPR) have gained significant attention as a promising synthetic biology technique, but there are concerns about the potential for persistent activation of CRISPR-associated protein (Cas) and subsequent off-target effects. This forum focuses on advances in anti-CRISPR studies based on non-protein substances in the hope of developing effective anti-CRISPR strategies to mitigate these concerns.
Exploiting CRISPR/Cas: Interference Mechanisms and Applications

Hagen Richter,Lennart Randau,André Plagens

DOI: https://doi.org/10.3390/ijms140714518

IF: 5.6

2013-07-12

International Journal of Molecular Sciences

Abstract:The discovery of biological concepts can often provide a framework for the development of novel molecular tools, which can help us to further understand and manipulate life. One recent example is the elucidation of the prokaryotic adaptive immune system, clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) that protects bacteria and archaea against viruses or conjugative plasmids. The immunity is based on small RNA molecules that are incorporated into versatile multi-domain proteins or protein complexes and specifically target viral nucleic acids via base complementarity. CRISPR/Cas interference machines are utilized to develop novel genome editing tools for different organisms. Here, we will review the latest progress in the elucidation and application of prokaryotic CRISPR/Cas systems and discuss possible future approaches to exploit the potential of these interference machineries.

biochemistry & molecular biology,chemistry, multidisciplinary
Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins

Lingguang Yang,Yi Zhang,Peipei Yin,Yue Feng

DOI: https://doi.org/10.1080/15476286.2021.1985347

2021-10-04

RNA Biology

Abstract:Phage infection is one of the major threats to prokaryotic survival, and prokaryotes in turn have evolved multiple protection approaches to fight against this challenge. Various delicate mechanisms have been discovered from this eternal arms race, among which the CRISPR-Cas systems are the prokaryotic adaptive immune systems and phages evolve diverse anti-CRISPR (Acr) proteins to evade this immunity. Until now, about 90 families of Acr proteins have been identified, out of which 24 families were verified to fight against subtype I-F CRISPR-Cas systems. Here, we review the structural and biochemical mechanisms of the characterized type I-F Acr proteins, classify their inhibition mechanisms into two major groups and provide insights for future studies of other Acr proteins. Understanding Acr proteins in this context will lead to a variety of practical applications in genome editing and also provide exciting insights into the molecular arms race between prokaryotes and phages.

biochemistry & molecular biology
Potent Cas9 inhibition in bacterial and human cells by new anti-CRISPR protein families

Jooyoung Lee,Aamir Mir,Alireza Edraki,Bianca Garcia,Nadia Amrani,Hannah E. Lou,Ildar Gainetdinov,April Pawluk,Raed Ibraheim,Xin D. Gao,Pengpeng Liu,Alan R. Davidson,Karen L. Maxwell,Erik J. Sontheimer

DOI: https://doi.org/10.1101/350504

2018-06-20

Abstract:CRISPR-Cas systems are widely used for genome engineering technologies, and in their natural setting, they play crucial roles in bacterial and archaeal adaptive immunity, protecting against phages and other mobile genetic elements. Previously we discovered bacteriophage-encoded Cas9-specific anti-CRISPR (Acr) proteins that serve as countermeasures against host bacterial immunity by inactivating their CRISPR-Cas systems 1 . We hypothesized that the evolutionary advantages conferred by anti-CRISPRs would drive the widespread occurrence of these proteins in nature 2–4 . We have identified new anti-CRISPRs using the bioinformatic approach that successfully identified previous Acr proteins 1 against Neisseria meningitidis Cas9 (NmeCas9). In this work we report two novel anti-CRISPR families in strains of Haemophilus parainfluenzae and Simonsiella muelleri , both of which harbor type II-C CRISPR-Cas systems 5 . We characterize the type II-C Cas9 orthologs from H. parainfluenzae and S. muelleri , show that the newly identified Acrs are able to inhibit these systems, and define important features of their inhibitory mechanisms. The S. muelleri Acr is the most potent NmeCas9 inhibitor identified to date. Although inhibition of NmeCas9 by anti-CRISPRs from H. parainfluenzae and S. muelleri reveals cross-species inhibitory activity, more distantly related type II-C Cas9s are not inhibited by these proteins. The specificities of anti-CRISPRs and divergent Cas9s appear to reflect co-evolution of their strategies to combat or evade each other. Finally, we validate these new anti-CRISPR proteins as potent off-switches for Cas9 genome engineering applications.
Computational design of anti-CRISPR proteins with improved inhibition potency and expanded specificity

Jan Mathony,Zander Harteveld,Carolin Schmelas,Julius Upmeier zu Belzen,Sabine Aschenbrenner,Mareike D. Hoffmann,Christina Stengl,Andreas Scheck,Stéphane Rosset,Dirk Grimm,Roland Eils,Bruno E. Correia,Dominik Niopek

DOI: https://doi.org/10.1101/685032

2019-06-27

Abstract:Abstract Anti-CRISPR (Acr) proteins are bacteriophage-derived antagonists of CRISPR-Cas systems. To date, Acrs were obtained either by mining sequence databanks or experimentally screening phage collections, both of which yield a limited repertoire of naturally occurring variants. Here, we applied structure-based engineering on AcrIIC1, a broad-spectrum inhibitor of type II-C CRISPR systems, to improve its efficacy and expand its specificity. We first show that fusing exogenous protein domains into AcrIIC1 dramatically enhances inhibition of the natural Neisseria meningitidis Cas9 target. Then, using structure-guided design, we converted AcrIIC1 into AcrX, a potent inhibitor of the type II-A CRISPR-Cas9 from Staphylococcus aureus widely applied for in vivo genome editing. Our work introduces designer Acrs as important biotechnological tools and provides an innovative strategy to safeguard the CRISPR technology.
Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer

Caroline Mahendra,Kathleen A Christie,Beatriz A Osuna,Rafael Pinilla-Redondo,Benjamin P Kleinstiver,Joseph Bondy-Denomy

DOI: https://doi.org/10.1038/s41564-020-0692-2

Abstract:CRISPR-Cas adaptive immune systems protect bacteria and archaea against their invading genetic parasites, including bacteriophages/viruses and plasmids. In response to this immunity, many phages have anti-CRISPR (Acr) proteins that inhibit CRISPR-Cas targeting. To date, anti-CRISPR genes have primarily been discovered in phage or prophage genomes. Here, we uncovered acr loci on plasmids and other conjugative elements present in Firmicutes using the Listeria acrIIA1 gene as a marker. The four identified genes, found in Listeria, Enterococcus, Streptococcus and Staphylococcus genomes, can inhibit type II-A SpyCas9 or SauCas9, and are thus named acrIIA16-19. In Enterococcus faecalis, conjugation of a Cas9-targeted plasmid was enhanced by anti-CRISPRs derived from Enterococcus conjugative elements, highlighting a role for Acrs in the dissemination of plasmids. Reciprocal co-immunoprecipitation showed that each Acr protein interacts with Cas9, and Cas9-Acr complexes were unable to cleave DNA. Northern blotting suggests that these anti-CRISPRs manipulate single guide RNA length, loading or stability. Mirroring their activity in bacteria, AcrIIA16 and AcrIIA17 provide robust and highly potent broad-spectrum inhibition of distinct Cas9 proteins in human cells (for example, SpyCas9, SauCas9, SthCas9, NmeCas9 and CjeCas9). This work presents a focused analysis of non-phage Acr proteins, demonstrating a role in horizontal gene transfer bolstered by broad-spectrum CRISPR-Cas9 inhibition.
Structure-guided discovery of anti-CRISPR and anti-phage defense proteins

Ning Duan,Emily Hand,Mannuku Pheko,Shikha Sharma,Akintunde Emiola

DOI: https://doi.org/10.1038/s41467-024-45068-7

IF: 16.6

2024-01-20

Nature Communications

Abstract:Abstract Bacteria use a variety of defense systems to protect themselves from phage infection. In turn, phages have evolved diverse counter-defense measures to overcome host defenses. Here, we use protein structural similarity and gene co-occurrence analyses to screen >66 million viral protein sequences and >330,000 metagenome-assembled genomes for the identification of anti-phage and counter-defense systems. We predict structures for ~300,000 proteins and perform large-scale, pairwise comparison to known anti-CRISPR (Acr) and anti-phage proteins to identify structural homologs that otherwise may not be uncovered using primary sequence search. This way, we identify a Bacteroidota phage Acr protein that inhibits Cas12a, and an Akkermansia muciniphila anti-phage defense protein, termed BxaP. Gene bxaP is found in loci encoding Bacteriophage Exclusion (BREX) and restriction-modification defense systems, but confers immunity independently. Our work highlights the advantage of combining protein structural features and gene co-localization information in studying host-phage interactions.

multidisciplinary sciences
Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins

Ning Jia,Dinshaw J. Patel

DOI: https://doi.org/10.1038/s41580-021-00371-9

IF: 113.915

2021-06-04

Nature Reviews Molecular Cell Biology

Abstract:CRISPR loci and Cas proteins provide adaptive immunity in prokaryotes against invading bacteriophages and plasmids. In response, bacteriophages have evolved a broad spectrum of anti-CRISPR proteins (anti-CRISPRs) to counteract and overcome this immunity pathway. Numerous anti-CRISPRs have been identified to date, which suppress single-subunit Cas effectors (in CRISPR class 2, type II, V and VI systems) and multisubunit Cascade effectors (in CRISPR class 1, type I and III systems). Crystallography and cryo-electron microscopy structural studies of anti-CRISPRs bound to effector complexes, complemented by functional experiments in vitro and in vivo, have identified four major CRISPR–Cas suppression mechanisms: inhibition of CRISPR–Cas complex assembly, blocking of target binding, prevention of target cleavage, and degradation of cyclic oligonucleotide signalling molecules. In this Review, we discuss novel mechanistic insights into anti-CRISPR function that have emerged from X-ray crystallography and cryo-electron microscopy studies, and how these structures in combination with function studies provide valuable tools for the ever-growing CRISPR–Cas biotechnology toolbox, to be used for precise and robust genome editing and other applications.

cell biology
Bacteriophages suppress CRISPR–Cas immunity using RNA-based anti-CRISPRs

Sarah Camara-Wilpert,David Mayo-Muñoz,Jakob Russel,Robert D. Fagerlund,Jonas S. Madsen,Peter C. Fineran,Søren J. Sørensen,Rafael Pinilla-Redondo

DOI: https://doi.org/10.1038/s41586-023-06612-5

IF: 64.8

2023-10-19

Nature

Abstract:Many bacteria use CRISPR–Cas systems to combat mobile genetic elements, such as bacteriophages and plasmids 1 . In turn, these invasive elements have evolved anti-CRISPR proteins to block host immunity 2,3 . Here we unveil a distinct type of CRISPR–Cas Inhibition strategy that is based on small non-coding R NA a nti- CR ISPRs (Racrs). Racrs mimic the repeats found in CRISPR arrays and are encoded in viral genomes as solitary repeat units 4 . We show that a prophage-encoded Racr strongly inhibits the type I-F CRISPR–Cas system by interacting specifically with Cas6f and Cas7f, resulting in the formation of an aberrant Cas subcomplex. We identified Racr candidates for almost all CRISPR–Cas types encoded by a diverse range of viruses and plasmids, often in the genetic context of other anti-CRISPR genes 5 . Functional testing of nine candidates spanning the two CRISPR–Cas classes confirmed their strong immune inhibitory function. Our results demonstrate that molecular mimicry of CRISPR repeats is a widespread anti-CRISPR strategy, which opens the door to potential biotechnological applications 6 .

multidisciplinary sciences
Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity

Adair L Borges,Jenny Y Zhang,MaryClare F Rollins,Beatriz A Osuna,Blake Wiedenheft,Joseph Bondy-Denomy

DOI: https://doi.org/10.1016/j.cell.2018.06.013

IF: 64.5

2018-08-09

Cell

Abstract:Bacteria utilize CRISPR-Cas adaptive immune systems for protection from bacteriophages (phages), and some phages produce anti-CRISPR (Acr) proteins that inhibit immune function. Despite thorough mechanistic and structural information for some Acr proteins, how they are deployed and utilized by a phage during infection is unknown. Here, we show that Acr production does not guarantee phage replication when faced with CRISPR-Cas immunity, but instead, infections fail when phage population numbers fall below a critical threshold. Infections succeed only if a sufficient Acr dose is contributed to a single cell by multiple phage genomes. The production of Acr proteins by phage genomes that fail to replicate leave the cell immunosuppressed, which predisposes the cell for successful infection by other phages in the population. This altruistic mechanism for CRISPR-Cas inhibition demonstrates inter-virus cooperation that may also manifest in other host-parasite interactions.
CRISPR-repressed toxin-antitoxin provides population-level immunity against diverse anti-CRISPR elements

Xian Shu,Rui Wang,Zhihua Li,Qiong Xue,Jiajun Wang,Jingfang Liu,Feiyue Cheng,Chao Liu,Huiwei Zhao,Chunyi Hu,Jie Li,Songying Ouyang,Ming Li

DOI: https://doi.org/10.1101/2024.01.05.574328

2024-01-05

Abstract:Prokaryotic CRISPR-Cas systems are highly vulnerable to phage-encoded anti-CRISPR (Acr) factors. How CRISPR-Cas systems protect themselves remains unclear. Here, we uncovered a broad-spectrum anti-anti-CRISPR strategy involving a phage-derived toxic protein. Transcription of this toxin is normally reppressed by the CRISPR-Cas effector, but is activated to halt cell division when the effector is inhibited by any anti-CRISPR proteins or RNAs. We showed that this abortive infection-like effect efficiently expels Acr elements from bacterial population. Furthermore, we exploited this anti-anti-CRISPR mechanism to develop a screening method for specific Acr candidates for a CRISPR-Cas system, and successfully identified two distinct Acr proteins that enhance the binding of CRISPR effector to non-target DNA. Our data highlight the broad-spectrum role of CRISPR-repressed toxins in counteracting various types of Acr factors, which illuminates that the regulatory function of CRISPR-Cas confers host cells herd immunity against Acr-encoding genetic invaders, no matter they are CRISPR-targeted or not.

Microbiology
Diverse mechanisms of CRISPR-Cas9 inhibition by type II anti-CRISPR proteins

Sungwon Hwang,Karen L. Maxwell

DOI: https://doi.org/10.1016/j.jmb.2023.168041

IF: 6.151

2023-03-09

Journal of Molecular Biology

Abstract:Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas (CRISPR-associated proteins) systems provide bacteria and archaea with an adaptive immune response against invasion by mobile genetic elements like phages, plasmids, and transposons. These systems have been repurposed as very powerful biotechnological tools for gene editing applications in both bacterial and eukaryotic systems. The discovery of natural off-switches for CRISPR-Cas systems, known as anti-CRISPR proteins, provided a mechanism for controlling CRISPR-Cas activity and opened avenues for the development of more precise editing tools. In this review, we focus on the inhibitory mechanisms of anti-CRISPRs that are active against type II CRISPR-Cas systems and briefly discuss their biotechnological applications.

biochemistry & molecular biology

Anti-CRISPRs deconstruct bacterial defense

Anti-CRISPR: discovery, mechanism and function

A broad anti-anti-CRISPR strategy

Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering

If you can't beat them, join them: Anti-CRISPR proteins derived from CRISPR-associated genes

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems

The novel anti-CRISPR AcrIIA22 relieves DNA torsion in target plasmids and impairs SpyCas9 activity

Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies

Using CRISPR-Cas systems as antimicrobials

Anti-CRISPR with Non-Protein Substances.

Exploiting CRISPR/Cas: Interference Mechanisms and Applications

Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins

Potent Cas9 inhibition in bacterial and human cells by new anti-CRISPR protein families

Computational design of anti-CRISPR proteins with improved inhibition potency and expanded specificity

Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer

Structure-guided discovery of anti-CRISPR and anti-phage defense proteins

Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins

Bacteriophages suppress CRISPR–Cas immunity using RNA-based anti-CRISPRs

Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity

CRISPR-repressed toxin-antitoxin provides population-level immunity against diverse anti-CRISPR elements

Diverse mechanisms of CRISPR-Cas9 inhibition by type II anti-CRISPR proteins